SEC Tracker
Get the app
BSX · XBRL financial data

Boston Scientific financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (BSX's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Revenue from contracts with customers3,725*3,8564,1204,2094,561*4,6635,0615,0655,286*5,2035,4425,138
Cost of goods and services sold1,147*1,2091,2701,3121,466*1,4531,6371,5231,608*1,5901,5941,710
Gross profit2,579*2,6482,8502,8973,095*3,2103,4243,5423,679*3,6143,8483,428
Selling, general and administrative1,379*1,3641,4461,5621,612*1,5971,7161,7411,834*1,7811,8031,683
Total operating expenses1,995*1,9732,3302,1642,420*2,2882,6052,4942,854*2,5132,6702,600
Other operating income (expense)15*(2)23(14)9*34(213)23————
Operating income (loss)584*675520733675*9218191,048825*1,1011,178828
Interest expense65*69777980*82908790*9096100
Other income (expense)(15)*2(23)14(314)*(116)122(110)(125)*61(118)(95)
Income tax expense (benefit)1*1159820023*13314618330*(176)155153
Earnings per share, basic USD per share—0.340.220.32—0.460.540.51—0.900.620.40
Earnings per share, diluted USD per share—0.330.220.32—0.450.530.51—0.900.610.40
Weighted average shares, basic millions of shares1,465*1,4681,4711,4731,474*1,4771,4801,4821,483*1,4851,4701,449
Weighted average shares, diluted millions of shares1,476*1,4821,4841,4871,490*1,4931,4941,4961,496*1,4951,4751,452

Balance sheet

CSV

Fiscal quarters (BSX's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Cash and cash equivalents8652,3292,9132,5024147255341,2751,9651,453539609
Inventory2,4842,5612,6082,7532,8102,8672,8612,9212,9433,1173,2353,317
Prepaid and other current assets621671756674831756613701660729760745
Total current assets6,5148,1858,9918,7616,9207,3357,1218,0358,7948,6847,9728,164
Property and equipment, net2,8592,8972,9513,0723,2943,3893,4613,7954,0364,0634,1264,183
Right-of-use asset439430416426449448492495465547553537
Goodwill14,38714,36114,39715,03317,08917,34018,07618,21418,28218,53618,64018,736
Total assets35,13636,66937,10838,07839,39540,14041,55942,70743,67344,35145,21645,461
Accounts payable9429219069079601,0049621,0021,1441,1411,2311,250
Accrued liabilities2,6462,0832,3202,4602,7732,3542,7972,9813,2012,5142,7562,969
Total current liabilities4,9334,9165,5765,9106,3995,0585,1905,3285,4394,5716,4285,982
Lease liability, non-current390382365373401399440445446———
Retained earnings8191,3141,6392,1072,6733,3474,1444,8995,5716,9127,8188,400
Total stockholders' equity19,28219,92620,37120,70821,77022,21222,41823,39424,23325,86424,93025,630
Total liabilities and equity35,13636,66937,10838,07839,39540,14041,55942,70743,67344,35145,21645,461
Common shares outstanding (cover page) millions of shares1,4671,4701,4731,4741,4761,4791,4821,4821,4841,4861,4491,449

Cash flows

CSV

Fiscal quarters (BSX's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Stock-based compensation59*6366*68*69*7475*79*71*8387*72*
Depreciation and amortization313*304311*306*348*325336*342*365*351355*361*
Net cash from operating activities957*164813*1,002*1,456*5411,286*1,343*1,364*3481,474*1,048*
Purchases of property and equipment267*179155*179*277*187157*181*351*177195*180*
Net cash from investing activities(1,053)*(285)(271)*(1,427)*(3,704)*(500)(1,126)*(502)*(512)*(591)(1,956)*(437)*
Share repurchases———————0*———0*
Dividends paid0*00*0*0*———————
Net cash from financing activities15*1,56924*7*214*233(340)*(104)*(184)*(260)(410)*(569)*
Net change in cash(77)*1,441565*(412)*(2,044)*314(179)*735*671*(504)(890)*44*

Compare with peers

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($M)Revenue, quarter ($M)Operating cash flow, quarter ($M)Shares outstandingQuarter
Boston Scientific6095,1381,048*1.4B 10-QSep 30, 2026
Stryker3,2716,5201,461*380.7M 10-QSep 30, 2026
Intuitive Surgical2,9783,0491,224*346.6M 10-QSep 30, 2026
Medtronic1,6919,7561,7931.3B 10-QJul 31, 2026
3M4,8356,584486*516.7M 10-QSep 30, 2026
Becton Dickinson7084,983not reported272.4M 10-QJun 30, 2026
Edwards Lifesciences2,9071,741652*576.4M 10-QJun 30, 2026
Resmed1,0111,415422140.7M 10-QSep 30, 2026
Dexcom9611,345326*373.0M 10-QSep 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.